Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

HCI Connects Precision Medicine With Patient-Centered Care

December 19th 2014

Latest News & Insight: December 19, 2014

December 19th 2014

FDA Approves Ramucirumab for NSCLC

December 12th 2014

The FDA has approved the VEGFR-2 inhibitor ramucirumab (Cyramza) in combination with docetaxel for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumor has progressed during or following treatment with platinum-based chemotherapy.

Analyzing CTCs Using Next-Generation Sequencing

December 5th 2014

Next-Generation of CTC Technology

December 5th 2014

Clinical Utility of Circulating Tumor Cells

December 5th 2014

Latest News & Insight: December 5, 2014

December 5th 2014

Race, Hospital, and Insurance Status Matters For Patients With Inoperable Stage I Lung Cancer

December 2nd 2014

Despite the proven benefits of stereotactic body radiotherapy (SBRT) for patients with inoperable stage I non–small cell lung cancer (NSCLC), whether such patients are offered it depends on their race, insurance status, and the type of facility where they are being treated.

Dr. Spigel Discusses the Development of Onartuzumab for the Treatment of Lung Cancer

December 2nd 2014

David Spigel, MD, director, Lung Cancer Research Program, Sarah Cannon Research Institute, discusses the development of onartuzumab for the treatment of patients with lung cancer.

From Bedside to Bench

November 29th 2014

Based on a current laboratory research project, Zarah Dulce F. Lucas, MD, discusses microRNAs and their potential to predict brain metastases in patients with triple-negative and HER2-positive breast cancer.

Latest News & Insight: November 26, 2014

November 27th 2014

Levy Provides Update on Squamous Cell Lung Cancer Treatments

November 22nd 2014

Recent advances with immune checkpoint inhibitors could improve outcomes for patients with squamous cell non-small cell lung cancer, a traditionally hard to treat histology.

Making EGFR-Positive NSCLC a Chronic Disease

November 20th 2014

Team Approach to Lung Cancer Care Is Essential

November 20th 2014

Reconsideration of Gefitinib in EGFR-Mutant NSCLC

November 20th 2014

Treating Acquired Resistance to TKIs in NSCLC

November 20th 2014

Dosing Strategies for Managing TKI-Related Side Effects

November 20th 2014

Patient-reported Outcomes with TKIs

November 20th 2014

Frontline Afatinib in EGFR-Mutant NSCLC

November 20th 2014

Frontline Treatment of Advanced NSCLC

November 20th 2014

NEXT PAGE
PREVIOUS PAGE